Background: Depressive symptoms are prevalent in patients with mild cognitive impairment (MCI) and are considered to be a risk factor for progression to dementia.
Objective: The purpose of this study was to evaluate whether depressive symptoms in MCI promote disease progression in a manner related to amyloid status, and to determine the relationship between depressive symptoms and longitudinal cerebral structural changes.
Methods: Baseline data for 336 patients with MCI (75 with depression and 261 without) from the Alzheimer’s Disease Neuroimaging Initiative study were analyzed. All participants underwent comprehensive cognitive testing, volumetric magnetic resonance imaging (MRI), and [18F]AV45 positron emission tomography amyloid imaging. Depressive symptoms were measured using the Neuropsychiatric Inventory Questionnaire. A voxel-based morphometric analysis using volumetric brain MRI data was used to compare longitudinal structural changes related to depressive symptoms.
Results: The conversion rate to dementia was different between patients with and without depression in amyloid-positive MCI (40.8% versus 19.7%, respectively; p = 0.006). Patients who were amyloid-positive at baseline also exhibited a greater degree of 2-year cognitive decline. Depression in amyloid-positive MCI was associated with longitudinal cortical atrophy in the left cingulate gyrus.
Conclusion: Our study indicates that the presence of depressive symptoms in patients with amyloid-positive MCI is associated with higher progression to dementia and longitudinal cortical atrophy.
DawoodS (2016) Caregiver burden, quality of life and vulnerability towards psychopathology in caregivers of patients with dementia/Alzheimer’s disease. J Coll Physicians Surg Pak26, 892–895.
2.
HuijbersW, MorminoEC, SchultzAP, WigmanS, WardAM, LarvieM, AmariglioRE, MarshallGA, RentzDM, JohnsonKA, SperlingRA (2015) Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression. Brain138, 1023–1035.
IsmailZ, ElbayoumiH, FischerCE, HoganDB, MillikinCP, SchweizerT, MortbyME, SmithEE, PattenSB, FiestKM (2017) Prevalence of depression in patients with mild cognitive impairment: A systematic review and meta-analysis. JAMA Psychiatry74, 58–67.
10.
Van der MusseleS, FransenE, StruyfsH, LuyckxJ, MariënP, SaerensJ, SomersN, GoemanJ, De DeynPP, EngelborghsS (2014) Depression in mild cognitive impairment is associated with progression to Alzheimer’s disease: A longitudinal study. J Alzheimers Dis42, 1239–1250.
11.
GabryelewiczT, StyczynskaM, LuczywekE, BarczakA, PfefferA, AndrosiukW, Chodakowska-ZebrowskaM, WasiakB, PeplonskaB, BarcikowskaM (2007) The rate of conversion of mild cognitive impairment to dementia: Predictive role of depression. Int J Geriatr Psychiatry22, 563–567.
12.
HoudeM, BergmanH, WhiteheadV, ChertkowH (2008) A predictive depression pattern in mild cognitive impairment. Int J Geriatr Psychiatry23, 1028–1033.
13.
BrodatyH, ConnorsMH, AmesD, WoodwardM, on behalf of the PRIME study group (2014) Progression from mild cognitive impairment to dementia: A 3-year longitudinal study. Aust N Z J Psychiatry48, 1137–1142.
14.
ChungJK, PlitmanE, NakajimaS, ChakravartyMM, CaravaggioF, TakeuchiH, GerretsenP, IwataY, PatelR, MulsantBH, Graff-GuerreroA, for the Alzheimer’s Disease Neuroimaging Initiative (2016) Depressive symptoms and small hippocampal volume accelerate the progression to dementia from mild cognitive impairment. J Alzheimers Dis49, 743–754.
FolsteinMF, FolsteinSE, McHughPR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res12, 189–198.
17.
MorrisJC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology43, 2412–2414.
JohnsonKA, MinoshimaS, BohnenNI, DonohoeKJ, FosterNL, HerscovitchP, KarlawishJH, RoweCC, CarrilloMC, HartleyDM, HedrickS, PappasV, ThiesWH (2013) Alzheimer’s Association, Society of Nuclear Medicine and Molecular Imaging, Amyloid Imaging Taskforce, Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association. Alzheimers Dement9, e1–16.
VillemagneVL, RoweCC, MacfarlaneS, NovakovicKE, MastersCL (2005) Imaginem oblivionis: The prospects of neuroimaging for early detection of Alzheimer’s disease. J Clin Neurosci12, 221–230.
Alemán-GómezY, Melie-GarcíaL., Valdés-HernandezP (2006) IBASPM: Toolbox for automatic parcellation of brain structures. In 12th Annual Meeting of the Organization for Human Brain Mapping, June 11-15, 2006, Florence, Italy.
26.
ModregoPJ, FerrándezJ (2004) Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: A prospective cohort study. Arch Neurol61, 1290–1293.
27.
SacuiuS, InselPS, MuellerS, TosunD, MattssonN, JackCR, DeCarliC, PetersenR, AisenPS, WeinerMW, MackinRS (2016) Chronic depressive symptomatology in mild cognitive impairment is associated with frontal atrophy rate which hastens conversion to Alzheimer dementia. Am J Geriatr Psychiatry24, 126–135.
28.
WinbladB, PalmerK, KivipeltoM, JelicV, FratiglioniL, WahlundLO, NordbergA, BäckmanL, AlbertM, AlmkvistO, AraiH, BasunH, BlennowK, de LeonM, DeCarliC, ErkinjunttiT, GiacobiniE, GraffC, HardyJ, JackC, JormA, RitchieK, van DuijnC, VisserP, PetersenRC (2004) Mild cognitive impairment–beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med256, 240–246.
29.
AlbertMS, DeKoskyST, DicksonD, DuboisB, FeldmanHH, FoxNC, GamstA, HoltzmanDM, JagustWJ, PetersenRC, SnyderPJ, CarrilloMC, ThiesB, PhelpsCH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 270–279.
30.
DickersonBC, StoubTR, ShahRC, SperlingRA, KillianyRJ, AlbertMS, HymanBT, BlackerD, Detoledo-MorrellL (2011) Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology76, 1395–1402.
31.
DickersonBC, BakkourA, SalatDH, FeczkoE, PachecoJ, GreveDN, GrodsteinF, WrightCI, BlackerD, RosasHD, SperlingRA, AtriA, GrowdonJH, HymanBT, MorrisJC, FischlB, BucknerRL (2009) The cortical signature of Alzheimer’s disease: Regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex19, 497–510.
32.
Tabatabaei-JafariH, ShawME, CherbuinN (2015) Cerebral atrophy in mild cognitive impairment: A systematic review with meta-analysis. Alzheimers Dement (Amst)1, 487–504.
33.
MaybergHS (2003) Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull65, 193–207.
34.
DrevetsWC, PriceJL, FureyML (2008) Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression. Brain Struct Funct213, 93–118.
35.
LebedevAV, BeyerMK, FritzeF, WestmanE, BallardC, AarslandD (2014) Cortical changes associated with depression and antidepressant use in Alzheimer and Lewy body dementia: An MRI surface-based morphometric study. Am J Geriatr Psychiatry22, 4-13.e1.
36.
LavretskyH, RoybalDJ, BallmaierM, TogaAW, KumarA (2005) Antidepressant exposure may protect against decrement in frontal gray matter volumes in geriatric depression. J Clin Psychiatry66, 964–967.
37.
MacFallJR, PayneME, ProvenzaleJE, KrishnanKR (2001) Medial orbital frontal lesions in late-onset depression. Biol Psychiatry49, 803–806.
38.
LaiT, PayneME, ByrumCE, SteffensDC, KrishnanKR (2000) Reduction of orbital frontal cortex volume in geriatric depression. Biol Psychiatry48, 971–975.
39.
LebedevaA, WestmanE, LebedevAV, LiX, WinbladB, SimmonsA, WahlundL-O, AarslandD, for the Alzheimer’s Disease Neuroimaging Initiative (2014) Structural brain changes associated with depressive symptoms in the elderly with Alzheimer’s disease. J Neurol Neurosurg Psychiatry85, 930–935.
40.
LimHK, JungWS, AhnKJ, WonWY, HahnC, LeeSY, KimI, LeeCU (2012) Regional cortical thickness and subcortical volume changes are associated with cognitive impairments in the drug-naive patients with late-onset depression. Neuropsychopharmacology37, 838–849.
41.
WuK-Y, HsiaoI-T, ChenC-S, ChenC-H, HsiehC-J, WaiY-Y, ChangC-J, TsengH-J, YenT-C, LiuC-Y, LinK-J (2014) Increased brain amyloid deposition in patients with a lifetime history of major depression: Evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography. Eur J Nucl Med Mol Imaging41, 714–722.
